Drawing for SUPERNUS PHARMACEUTICALS

USPTO serial 78558949

SUPERNUS PHARMACEUTICALS

Reviewed by CopyMark Law Group

Reg. 3336065Status 800Renewal
Filing date
Status date
Registration date
Nov 13, 2007
Examiner
SPARACINO, MARK V
Law office
TMEG LAW OFFICE 103

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 800: Status 800 means the registration was renewed after acceptable combined Section 8 and Section 9 filings. The mark remains registered for another 10-year term with active federal protection.

Need help with SUPERNUS PHARMACEUTICALS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $299*

Plus Government fees of $650

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Gregory S. Bernabeo

Gregory S. Bernabeo Saul Ewing Arnstein & Lehr LLP1500 Market Street37th FloorPhiladelphia, PA 19102

Goods and services

ClassDescriptionStatusFirst use
001[ Chemicals and excipients used in the manufacture of pharmaceuticals, namely, formulations which promote controlled release, reduced abuse potential, enhanced solubility, enhanced permeability or enhanced absorption of pharmaceutical agents ]SECTION 8 - CANCELLEDMar 21, 2007
005Pharmaceuticals preparations for the treatment of central nervous system disordersACTIVEMar 21, 2007
042[ Pharmaceutical drug development; pharmaceutical drug development and research services, namely, drug screening services; pharmaceutical development services for others, namely, evaluating the permeability and absorption of pharmaceuticals in the body and developing formulations to facilitate and improve the delivery of drugs into the body; pharmaceutical research and development services, namely, cell-based in vitro and in vivo screening services ]SECTION 8 - CANCELLEDJan 12, 2006

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Nov 20, 2017NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Nov 20, 2017RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Nov 20, 20179G8PREGISTERED - SEC. 9 GRANTED/CHECK RECORD FOR SEC. 8—
Nov 20, 20178PRTREGISTERED - PARTIAL SEC. 8 (10-YR) ACCEPTED—
Nov 20, 2017APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Oct 24, 2017E89RTEAS SECTION 8 & 9 RECEIVED—
Nov 13, 2016REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Dec 30, 2013NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Dec 30, 2013C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Dec 30, 2013APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 19, 2013815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED—
Dec 19, 2013E815TEAS SECTION 8 & 15 RECEIVED—
Dec 17, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Nov 18, 2010ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 18, 2010REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Nov 13, 2007R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 9, 2007REGVLAW OFFICE REGISTRATION REVIEW COMPLETED—
Oct 9, 2007ALIEASSIGNED TO LIE—
Sep 9, 2007CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Aug 30, 2007SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Aug 10, 2007IUAFUSE AMENDMENT FILED—
Aug 10, 2007EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 16, 2007EX1GSOU EXTENSION 1 GRANTED—
Feb 20, 2007EXT1SOU EXTENSION 1 FILED—
Feb 20, 2007MAILPAPER RECEIVED—
Aug 29, 2006NOAMNOA MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Jun 6, 2006PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
May 17, 2006NPUBNOTICE OF PUBLICATION—
Apr 19, 2006PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Apr 7, 2006ALIEASSIGNED TO LIE—
Apr 5, 2006ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP—
Apr 4, 2006CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 16, 2006ACECAMENDMENT FROM APPLICANT ENTERED—
Feb 27, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 27, 2006MAILPAPER RECEIVED—
Sep 1, 2005GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 1, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Aug 31, 2005DOCKASSIGNED TO EXAMINER—
Feb 9, 2005NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance